{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:45:40Z","timestamp":1792266340551,"version":"4.4.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:00:00Z","timestamp":1792195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:00:00Z","timestamp":1792195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Diabetes Metab Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>This review synthesizes the evidence regarding Type 2 diabetes mellitus (T2DM) as a critical modifiable risk factor for dementia through a life-course lens. The primary purpose is to move beyond the general association and determine how the timing and severity of T2DM, specifically age at onset, duration of disease, and glycemic instability, influence cognitive decline. Consequently, this paper seeks to answer the central research question: How do midlife versus late-life T2DM onset and cumulative glycemic exposure independently contribute to the long-term risk and biological pathways of late-life dementia?<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A structured narrative review was conducted using predefined search strategies and study selection criteria, focusing on peer-reviewed studies published 2020\u20132025 and key longitudinal cohorts. Studies included large prospective cohorts, population-based analyses, or meta-analyses reporting hazard ratios (HRs), relative risks (RRs), or odds ratios (ORs) for incident dementia, Alzheimer\u2019s disease (AD), or vascular dementia (VaD). Key exposures included midlife onset, duration, cumulative glycemic measures, and severe hypoglycemia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>T2DM was associated with a 1.3\u20131.8-fold increased risk of incident dementia. Earlier onset and longer duration showed graded risk increases, while higher cumulative glycemic burden and severe hypoglycemia were linked to greater dementia incidence. Associations were stronger for VaD than AD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Midlife T2DM appears to be a strong exposure-dependent risk factor for late-life dementia. Preventing T2DM onset, maintaining stable glycemic control, and minimizing hypoglycemia may be associated with lower future dementia risk, pending confirmation in interventional studies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s40200-026-02111-2","type":"journal-article","created":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T09:26:26Z","timestamp":1792229186000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Timing matters: a life-course review of midlife type 2 diabetes, exposure duration, and late-life dementia risk"],"prefix":"10.1007","volume":"25","author":[{"given":"Mrityunjay","family":"Sivakumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chakravarthy Marx","family":"Sadacharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,17]]},"reference":[{"issue":"10452","key":"2111_CR1","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0140-6736(24)01296-0","volume":"404","author":"G Livingston","year":"2024","unstructured":"Livingston G, Huntley J, Liu KY, Costafreda SG, Selb\u00e6k G, Alladi S, Ames D, Banerjee S, Burns A, Brayne C, Fox NC, Ferri CP, Gitlin LN, Howard R, Kales HC, Kivim\u00e4ki M, Larson EB, Nakasujja N, Rockwood K, Samus Q, Mukadam N. Dementia prevention, intervention, and care: 2024 report of the lancet standing commission. Lancet (London England). 2024;404(10452):572\u2013628. https:\/\/doi.org\/10.1016\/S0140-6736(24)01296-0.","journal-title":"Lancet (London England)"},{"issue":"10467","key":"2111_CR2","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1016\/S0140-6736(24)02317-1","volume":"404","author":"NCD Risk Factor Collaboration (NCD-RisC)","year":"2024","unstructured":"NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants. Lancet. 2024;404(10467):2077\u201393. https:\/\/doi.org\/10.1016\/S0140-6736(24)02317-1.","journal-title":"Lancet"},{"issue":"1","key":"2111_CR3","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13098-024-01346-4","volume":"16","author":"F Cao","year":"2024","unstructured":"Cao F, Yang F, Li J, Guo W, Zhang C, Gao F, Sun X, Zhou Y, Zhang W. The relationship between diabetes and the dementia risk: a meta-analysis. Diabetol Metab Syndr. 2024;16(1):101. https:\/\/doi.org\/10.1186\/s13098-024-01346-4.","journal-title":"Diabetol Metab Syndr"},{"key":"2111_CR4","doi-asserted-by":"publisher","unstructured":"Wu J, Li J, Qin X, Chen W. Association between diabetes mellitus and risk of Alzheimer\u2019s disease: a meta-analysis and systematic review [Abstract]. Front Endocrinol. 2026. https:\/\/doi.org\/10.3389\/fendo.2026.1736410\/abstract. https:\/\/www.frontiersin.org\/journals\/endocrinology\/articles\/.","DOI":"10.3389\/fendo.2026.1736410\/abstract"},{"issue":"10","key":"2111_CR5","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41574-018-0048-7","volume":"14","author":"GJ Biessels","year":"2018","unstructured":"Biessels GJ, Despa F. Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications. Nat Reviews Endocrinol. 2018;14(10):591\u2013604. https:\/\/doi.org\/10.1038\/s41574-018-0048-7.","journal-title":"Nat Reviews Endocrinol"},{"issue":"6","key":"2111_CR6","doi-asserted-by":"publisher","first-page":"4915","DOI":"10.1111\/dom.70677","volume":"28","author":"JE Jun","year":"2026","unstructured":"Jun JE, Kim S, Jeong IK, Kim JH. Dementia risk in type 1 and 2 diabetes: a nationwide population-based comparison. Diabetes Obes Metab. 2026;28(6):4915\u201325. https:\/\/doi.org\/10.1111\/dom.70677.","journal-title":"Diabetes Obes Metab"},{"issue":"6","key":"2111_CR7","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1001\/jamaneurol.2023.0697","volume":"80","author":"C Moran","year":"2023","unstructured":"Moran C, Lacy ME, Whitmer RA, Tsai AL, Quesenberry CP, Karter AJ, Adams AS, Gilsanz P. Glycemic control over multiple decades and dementia risk in people with type 2 diabetes. JAMA Neurol. 2023;80(6):597\u2013604. https:\/\/doi.org\/10.1001\/jamaneurol.2023.0697.","journal-title":"JAMA Neurol"},{"issue":"8","key":"2111_CR8","doi-asserted-by":"publisher","first-page":"e2425354","DOI":"10.1001\/jamanetworkopen.2024.25354","volume":"7","author":"PC Underwood","year":"2024","unstructured":"Underwood PC, Zhang L, Mohr DC, Prentice JC, Nelson RE, Budson AE, Conlin PR. Glycated hemoglobin A1c time in range and dementia in older adults with diabetes. JAMA Netw open. 2024;7(8):e2425354. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.25354.","journal-title":"JAMA Netw open"},{"issue":"2","key":"2111_CR9","doi-asserted-by":"publisher","first-page":"331","DOI":"10.2337\/dc22-1496","volume":"46","author":"W Alkabbani","year":"2023","unstructured":"Alkabbani W, Maxwell CJ, Marrie RA, Tyas SL, Lega IC, Gamble JM. Associations of mid- and late-life severe hypoglycemic episodes with incident dementia among patients with type 2 diabetes: a population-based cohort study. Diabetes Care. 2023;46(2):331\u201340. https:\/\/doi.org\/10.2337\/dc22-1496.","journal-title":"Diabetes Care"},{"key":"2111_CR10","doi-asserted-by":"publisher","unstructured":"Konda M, Lingutla C, Eruvuri V, Gatla SR, Vityala Y. (2025). Hypoglycemia as a risk factor for dementia in diabetes: a systematic review. Advanced Neurology. Advance online publication. https:\/\/doi.org\/10.36922\/AN025270077.","DOI":"10.36922\/AN025270077"},{"issue":"7","key":"2111_CR11","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.2337\/dc20-2850","volume":"44","author":"B Zheng","year":"2021","unstructured":"Zheng B, Su B, Price G, Tzoulaki I, Ahmadi-Abhari S, Middleton L. Glycemic control, diabetic complications, and risk of dementia in patients with diabetes: Results from a large U.K. cohort study. Diabetes Care. 2021;44(7):1556\u201363. https:\/\/doi.org\/10.2337\/dc20-2850.","journal-title":"Diabetes Care"},{"issue":"10","key":"2111_CR12","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1001\/jamaneurol.2017.1658","volume":"74","author":"RF Gottesman","year":"2017","unstructured":"Gottesman RF, Albert MS, Alonso A, Coker LH, Coresh J, Davis SM, Deal JA, McKhann GM, Mosley TH, Sharrett AR, Schneider ALC, Windham BG, Wruck LM, Knopman DS. Associations between midlife vascular risk factors and 25-year incident dementia in the atherosclerosis risk in communities (ARIC) cohort. JAMA Neurol. 2017;74(10):1246\u201354. https:\/\/doi.org\/10.1001\/jamaneurol.2017.1658.","journal-title":"JAMA Neurol"},{"issue":"1","key":"2111_CR13","doi-asserted-by":"publisher","first-page":"afab231","DOI":"10.1093\/ageing\/afab231","volume":"51","author":"C Reinke","year":"2022","unstructured":"Reinke C, Buchmann N, Fink A, Tegeler C, Demuth I, Doblhammer G. Diabetes duration and the risk of dementia: a cohort study based on German health claims data. Age Ageing. 2022;51(1):afab231. https:\/\/doi.org\/10.1093\/ageing\/afab231.","journal-title":"Age Ageing"},{"issue":"1 Suppl 1","key":"2111_CR14","doi-asserted-by":"publisher","first-page":"S266","DOI":"10.2337\/dc25-S013","volume":"48","author":"American Diabetes Association Professional Practice Committee","year":"2025","unstructured":"American Diabetes Association Professional Practice Committee. 13. Older adults: standards of care in diabetes-2025. Diabetes Care. 2025;48(1 Suppl 1):S266\u201382. https:\/\/doi.org\/10.2337\/dc25-S013.","journal-title":"Diabetes Care"},{"issue":"4","key":"2111_CR15","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1007\/s10787-025-01704-2","volume":"33","author":"M Dahiya","year":"2025","unstructured":"Dahiya M, Yadav M, Goyal C, Kumar A. Insulin resistance in Alzheimer\u2019s disease: 23 signalling mechanisms and therapeutics strategies. Inflammopharmacology. 2025;33(4):1817\u201331. https:\/\/doi.org\/10.1007\/s10787-025-01704-2.","journal-title":"Inflammopharmacology"},{"issue":"2","key":"2111_CR16","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1002\/ana.24992","volume":"82","author":"H Ly","year":"2017","unstructured":"Ly H, Verma N, Wu F, Liu M, Saatman KE, Nelson PT, Slevin JT, Goldstein LB, Biessels GJ, Despa F. Brain microvascular injury and white matter disease provoked by diabetes-associated hyperamylinemia. Ann Neurol. 2017;82(2):208\u201322. https:\/\/doi.org\/10.1002\/ana.24992.","journal-title":"Ann Neurol"},{"issue":"7","key":"2111_CR17","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s11011-025-01700-z","volume":"40","author":"A Raza","year":"2025","unstructured":"Raza A, Saleem S, Imran S, Rahman S, Haroon M, Razzaq A, Hussain A, Iqbal J, Sathian B. From metabolic dysregulation to neurodegenerative pathology: the role of hyperglycemia, oxidative stress, and blood-brain barrier breakdown in T2D-driven Alzheimer\u2019s disease. Metab Brain Dis. 2025;40(7):276. https:\/\/doi.org\/10.1007\/s11011-025-01700-z.","journal-title":"Metab Brain Dis"},{"key":"2111_CR18","doi-asserted-by":"publisher","first-page":"595962","DOI":"10.3389\/fendo.2020.595962","volume":"11","author":"DQ Wang","year":"2020","unstructured":"Wang DQ, Wang L, Wei MM, Xia XS, Tian XL, Cui XH, Li X. Relationship between type 2 diabetes and white matter hyperintensity: a systematic review. Front Endocrinol. 2020;11:595962. https:\/\/doi.org\/10.3389\/fendo.2020.595962.","journal-title":"Front Endocrinol"},{"key":"2111_CR19","doi-asserted-by":"publisher","first-page":"1614006","DOI":"10.3389\/fendo.2025.1614006","volume":"16","author":"S Wang","year":"2025","unstructured":"Wang S, Shi Y, Xin R, Kang H, Xiong H, Ren J. Exploring the role of insulin resistance in bridging the metabolic syndrome and Alzheimer\u2019s disease-a review of mechanistic studies. Front Endocrinol. 2025;16:1614006. https:\/\/doi.org\/10.3389\/fendo.2025.1614006.","journal-title":"Front Endocrinol"},{"key":"2111_CR20","doi-asserted-by":"publisher","first-page":"e079475","DOI":"10.1136\/bmj-2024-079475","volume":"386","author":"A Shin","year":"2024","unstructured":"Shin A, Koo BK, Lee JY, Kang EH. Risk of dementia after initiation of sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in adults aged 40\u201369 years with type 2 diabetes: population based cohort study. BMJ (Clinical Res ed). 2024;386:e079475. https:\/\/doi.org\/10.1136\/bmj-2024-079475.","journal-title":"BMJ (Clinical Res ed)"},{"issue":"3","key":"2111_CR21","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1177\/13872877251319054","volume":"104","author":"EK Hui","year":"2025","unstructured":"Hui EK, Mukadam N, Kohl G, Livingston G. Effect of diabetes medications on the risk of developing dementia, mild cognitive impairment, or cognitive decline: A systematic review and meta-analysis. J Alzheimer\u2019s disease: JAD. 2025;104(3):627\u201348. https:\/\/doi.org\/10.1177\/13872877251319054.","journal-title":"J Alzheimer\u2019s disease: JAD"},{"key":"2111_CR22","doi-asserted-by":"publisher","unstructured":"Cheng C-H, Thuy Dung Nguyen T, Peter Wst, Ou H-T. 21-OR: systematic review and meta-analysis of the association of SGLT2 inhibitors and GLP-1 receptor agonists on the risk of dementia 24 in patients with type 2 diabetes. Diabetes. 2025;74(Supplement1). https:\/\/doi.org\/10.2337\/db25-21-OR.","DOI":"10.2337\/db25-21-OR"},{"issue":"7","key":"2111_CR23","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/S2213-8587(21)00086-3","volume":"9","author":"AM Jacobson","year":"2021","unstructured":"Jacobson AM, Ryan CM, Braffett BH, et al. Cognitive performance declines in older adults with type 1 diabetes: results from 32 years of follow-up in the DCCT and EDIC Study. Lancet Diabetes Endocrinol. 2021;9(7):436\u201345. https:\/\/doi.org\/10.1016\/S2213-8587(21)00086-3.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"2111_CR24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s40615-023-01848-3","volume":"12","author":"H Kahlenberg","year":"2025","unstructured":"Kahlenberg H, Jiroutek MR, Misciagno SA. Ethnic and racial disparities in the association between type II diabetes mellitus and dementia. J racial ethnic health disparities. 2025;12(1):41\u20138. https:\/\/doi.org\/10.1007\/s40615-023-01848-3.","journal-title":"J racial ethnic health disparities"},{"key":"2111_CR25","doi-asserted-by":"publisher","unstructured":"Dawson AZ, Egede LE. 1253-P: differential risk of dementia in older adults with diabetes by race\/ethnicity, gender, and age\u2014health and retirement study 1992\u20132020. Diabetes. 2024;73(Supplement1). https:\/\/doi.org\/10.2337\/db24-1253-P.","DOI":"10.2337\/db24-1253-P"},{"issue":"16","key":"2111_CR26","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1001\/jama.2021.4001","volume":"325","author":"C Barbiellini Amidei","year":"2021","unstructured":"Barbiellini Amidei C, Fayosse A, Dumurgier J, Machado-Fragua MD, Tabak AG, van Sloten T, Kivim\u00e4ki M, Dugravot A, Sabia S, Singh-Manoux A. Association between age at diabetes onset and subsequent risk of dementia. JAMA. 2021;325(16):1640\u20139. https:\/\/doi.org\/10.1001\/jama.2021.4001.","journal-title":"JAMA"},{"issue":"9","key":"2111_CR27","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.2337\/dc24-0203","volume":"47","author":"J Hu","year":"2024","unstructured":"Hu J, Pike JR, Lutsey PL, Sharrett AR, Wagenknecht LE, Hughes TM, Seegmiller JC, Gottesman RF, Mosley TH, Selvin E, Fang M, Coresh J. Age of diabetes diagnosis and lifetime risk of dementia: the atherosclerosis risk in communities (ARIC) study. Diabetes Care. 2024;47(9):1576\u201383. https:\/\/doi.org\/10.2337\/dc24-0203.","journal-title":"Diabetes Care"},{"issue":"1","key":"2111_CR28","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s43088-025-00703-0","volume":"14","author":"H Majid","year":"2025","unstructured":"Majid H, Islam U, Kohli S, S., Nidhi. Diagnostic potential of serum biomarkers including HMGB1 and Klotho in cognitive impairment among type 2 diabetes mellitus patients: a case\u2013control study. Beni-Suef Univ J Basic Appl Sci. 2025;14(1):124. https:\/\/doi.org\/10.1186\/s43088-025-00703-0.","journal-title":"Beni-Suef Univ J Basic Appl Sci"},{"issue":"8","key":"2111_CR29","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1001\/jama.2021.12531","volume":"326","author":"US Preventive Services Task Force","year":"2021","unstructured":"US Preventive Services Task Force. Screening for prediabetes and type 2 diabetes: US preventive services task force recommendation statement. JAMA. 2021;326(8):736\u201343. https:\/\/doi.org\/10.1001\/jama.2021.12531.","journal-title":"JAMA"},{"issue":"6","key":"2111_CR30","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1056\/NEJMoa012512","volume":"346","author":"WC Knowler","year":"2002","unstructured":"Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM, Diabetes prevention program research group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393\u2013403. https:\/\/doi.org\/10.1056\/NEJMoa012512.","journal-title":"N Engl J Med"},{"issue":"1","key":"2111_CR31","doi-asserted-by":"publisher","first-page":"e71065","DOI":"10.1002\/alz.71065","volume":"22","author":"JM Li","year":"2026","unstructured":"Li JM, Gauen AM, Zmora R, Stephen JJ, Petito LC, Scholtens D, Peterson EA, KohliLynch C, Mansolf M, Sedaghat S, Giorgio K, Gross AL, Helmer C, Debette S, Soumar\u00e9 A, Ikram MA, Wolters FJ, Seshadri S, Satizabal CL, Himali J, Allen NB. Midlife and late-life population attributable fractions of risk factors for dementia in the United States: the dementia risk prediction project. Alzheimer\u2019s dementia: J Alzheimer\u2019s Association. 2026;22(1):e71065. https:\/\/doi.org\/10.1002\/alz.71065.","journal-title":"Alzheimer\u2019s dementia: J Alzheimer\u2019s Association"},{"issue":"7","key":"2111_CR32","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1002\/alz.12940","volume":"19","author":"PH Hwang","year":"2023","unstructured":"Hwang PH, Ang TFA, De Anda-Duran I, Liu X, Liu Y, Gurnani A, Mez J, Auerbach S, Joshi P, Yuan J, Devine S, Au R, Liu C. Examination of potentially modifiable dementia risk factors across the adult life course: The Framingham heart study. Alzheimer\u2019s Dement J Alzheimer\u2019s Assoc. 2023;19(7):2975\u201383. https:\/\/doi.org\/10.1002\/alz.12940.","journal-title":"Alzheimer\u2019s Dement J Alzheimer\u2019s Assoc"},{"issue":"1","key":"2111_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13293-023-00491-1","volume":"14","author":"C Zhou","year":"2023","unstructured":"Zhou C, Dong C, Xie Z, Hao W, Fu C, Sun H, Zhu D. Sex-specific associations between diabetes and dementia: the role of age at onset of disease, insulin use and complications. Biology sex differences. 2023;14(1):9. https:\/\/doi.org\/10.1186\/s13293-023-00491-1.","journal-title":"Biology sex differences"},{"issue":"14","key":"2111_CR34","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.2174\/1567205017666200103111253","volume":"16","author":"X-Y Li","year":"2020","unstructured":"Li X-Y, Zhang M, Xu W, Li J-Q, Cao X-P, Yu J-T, Tan L. Midlife modifiable risk factors for dementia: a systematic review and meta-analysis of 34 prospective cohort studies. Curr Alzheimer Res. 2020;16(14):1254\u201368. https:\/\/doi.org\/10.2174\/1567205017666200103111253.","journal-title":"Curr Alzheimer Res"},{"issue":"1","key":"2111_CR35","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13195-017-0236-z","volume":"9","author":"YC Fan","year":"2017","unstructured":"Fan YC, Hsu JL, Tung HY, Chou CC, Bai CH. Increased dementia risk predominantly in diabetes mellitus rather than in hypertension or hyperlipidemia: a population-based cohort study. Alzheimers Res Ther. 2017;9(1):7. https:\/\/doi.org\/10.1186\/s13195-017-0236-z.","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"2111_CR36","doi-asserted-by":"publisher","first-page":"e87095","DOI":"10.1371\/journal.pone.0087095","volume":"9","author":"CC Huang","year":"2014","unstructured":"Huang CC, Chung CM, Leu HB, Lin LY, Chiu CC, Hsu CY, Chiang CH, Huang PH, Chen TJ, Lin SJ, Chen JW, Chan WL. Diabetes mellitus and the risk of Alzheimer\u2019s 26 disease: a nationwide population-based study. PLoS ONE. 2014;9(1):e87095. https:\/\/doi.org\/10.1371\/journal.pone.0087095.","journal-title":"PLoS ONE"},{"issue":"4","key":"2111_CR37","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1159\/000362201","volume":"42","author":"K Mehlig","year":"2014","unstructured":"Mehlig K, Skoog I, Waern M, Miao Jonasson J, Lapidus L, Bj\u00f6rkelund C, Ostling S, Lissner L. Physical activity, weight status, diabetes and dementia: a 34-year follow-up of the population study of women in Gothenburg. Neuroepidemiology. 2014;42(4):252\u20139. https:\/\/doi.org\/10.1159\/000362201.","journal-title":"Neuroepidemiology"},{"issue":"3","key":"2111_CR38","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1001\/archinte.165.3.321","volume":"165","author":"A Rosengren","year":"2005","unstructured":"Rosengren A, Skoog I, Gustafson D, Wilhelmsen L. Body mass index, other cardiovascular risk factors, and hospitalization for dementia. Arch Intern Med. 2005;165(3):321\u20136. https:\/\/doi.org\/10.1001\/archinte.165.3.321.","journal-title":"Arch Intern Med"},{"issue":"10","key":"2111_CR39","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1212\/01.wnl.0000144278.79488.dd","volume":"63","author":"M Schnaider Beeri","year":"2004","unstructured":"Schnaider Beeri M, Goldbourt U, Silverman JM, Noy S, Schmeidler J, Ravona-Springer R, Sverdlick A, Davidson M. Diabetes mellitus in midlife and the risk of dementia three decades later. Neurol. 2004;63(10):1902\u20137. https:\/\/doi.org\/10.1212\/01.wnl.0000144278.79488.dd.","journal-title":"Neurol"}],"container-title":["Journal of Diabetes &amp; Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40200-026-02111-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40200-026-02111-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40200-026-02111-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:03:45Z","timestamp":1792263825000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40200-026-02111-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,17]]},"references-count":39,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2111"],"URL":"https:\/\/doi.org\/10.1007\/s40200-026-02111-2","relation":{},"ISSN":["2251-6581"],"issn-type":[{"value":"2251-6581","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,17]]},"assertion":[{"value":"5 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"291"}}